Difference between revisions of "Team:Lethbridge/Improve"
Keithaiken (Talk | contribs) |
|||
| (13 intermediate revisions by 3 users not shown) | |||
| Line 14: | Line 14: | ||
<div class="oneText-Wrapper"> | <div class="oneText-Wrapper"> | ||
<div class="oneText-Text"> | <div class="oneText-Text"> | ||
| − | <p class="f12">The following constructs are improved by being cloned and confirmed to be into the pSB1C3 plasmid, thus making them able to express in <i>E. coli</i> and used for iGEM user applications. Our project focuses on encapsulation of cargo by protein nanocompartments. This technology can be used to encapsulate cell free systems. The | + | <p class="f12">The following constructs are improved by being cloned and confirmed to be into the pSB1C3 plasmid, thus making them able to express in <i>E. coli</i> and used for iGEM user applications. Our project focuses on encapsulation of cargo by protein nanocompartments. This technology can be used to encapsulate cell free systems. The N<i>ex</i>t <i>vivo</i> project, designed by the <a href="https://2017.igem.org/Team:Lethbridge">Lethbridge iGEM team</a> in 2017 is therefore an important and viable application for our toolkit. We hope in the future to try encapsulating this system as an alternative to liposome encapsulation as previously proposed for this project. The ability to target cell types could increase the cell free technology we are still developing. Additionally, we hope that cell-free synthesis of protein nanocompartments can also be accomplished using our N<i>ex</i>t <i>vivo</i> system</p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 20: | Line 20: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| + | <div class="textImage-Wrapper"> | ||
| + | <div class="textImage-Text"> | ||
| + | <h3 id="left"><a href="" target="_blank" class="f12">Release Factor 1</a></div> | ||
| + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/b/bc/T--Lethbridge--RF12018.png" alt="RF1 construct"></center> | ||
| + | </div></div> | ||
| + | <div style="clear: both"></div> | ||
| − | + | <div class="oneText-Wrapper"><div class="oneText-Text"> | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | <div class="oneText-Wrapper"> | + | |
| − | <div class="oneText-Text"> | + | |
<ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443029" target="_blank">BBa_K2443029</a> | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443029" target="_blank">BBa_K2443029</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
<li>Brief description: Release factor 1 (RF1) works with release factor 2 and 3 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.</li> | <li>Brief description: Release factor 1 (RF1) works with release factor 2 and 3 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.</li> | ||
| − | </div> | + | </div></div> |
| − | </div> | + | |
| − | < | + | <div style="clear: both"></div> |
| + | |||
| + | <div class="textImage-Wrapper"> | ||
| + | <div class="textImage-Text"><a href="http://parts.igem.org/Part:BBa_K2683017" target="_blank" class="f12">Release Factor 2</a></div> | ||
| + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/3/3e/T--Lethbridge--RF22018.png"></center> | ||
| + | </div></div> | ||
| + | |||
| + | <div style="clear: both"></div> | ||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
<ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443030" target="_blank">BBa_K2443030</a> | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443030" target="_blank">BBa_K2443030</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
| Line 45: | Line 50: | ||
<li>Brief Description: Release factor 2 (RF2) works with release factors 1 and 2 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.</li> | <li>Brief Description: Release factor 2 (RF2) works with release factors 1 and 2 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.</li> | ||
</ul> | </ul> | ||
| − | </div> | + | </div></div> |
| − | </div> | + | |
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683018" target="_blank" class="f12">Cysteine tRNA Synthetase</a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/c/c9/T--Lethbridge--Cys2018.png" /></center> | |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443004" target="_blank">BBa_K2443004</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| Line 64: | Line 72: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683019" target="_blank" class="f12">Lysine tRNA Synthetase</a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/d/d8/T--Lethbridge--Lys2018.png" /></center> | |
| − | + | </div></div> | |
| − | + | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443012" target="_blank">BBa_K2443012</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief description: Lysine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis. | + | <li>Brief description: Lysine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis.</li> |
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 79: | Line 89: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683020" target="_blank" class="f12">Phenylalanine tRNA Synthetase alpha subunit (PheRS alpha) </a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/b/b6/T--Lethbridge--Phe2018.png" /></center> | |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443014" target="_blank">BBa_K2443014</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| Line 94: | Line 108: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683022" target="_blank" class="f12">Serine tRNA Synthetase (SerRS) </a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/e/ee/T--Lethbridge--Ser2018.png" /></center> | |
| − | + | </div></div> | |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443019" target="_blank">BBa_K2443019</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| Line 109: | Line 127: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683023" target="_blank" class="f12">Valine tRNA Synthetase (ValRS) </a></h2></div> |
| − | < | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/8/87/T--Lethbridge--Val2018.png" /></center> |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443023" target="_blank">BBa_K2443023</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief Description:Valine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis. | + | <li>Brief Description:Valine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis.</li> |
| − | + | ||
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 125: | Line 145: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683024" target="_blank" class="f12">Initiation Factor I (IF1)</a></h2></div> |
| − | < | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/f/fb/T--Lethbridge--IF12018.png" /></center> |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443024" target="_blank">BBa_K2443024</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief Description: IF1 is a prokaryotic protein that interacts with the ribosome by binding to the A site, preventing aminoacyl tRNA from entering the ribosome. | + | <li>Brief Description: IF1 is a prokaryotic protein that interacts with the ribosome by binding to the A site, preventing aminoacyl tRNA from entering the ribosome.</li> |
| − | + | ||
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 141: | Line 163: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683025" target="_blank" class="f12">Initiation Factor 3 (IF1)</a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/f/f6/T--Lethbridge--IF32018.png" /></center> | |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443025" target="_blank">BBa_K2443025</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief Description: IF-3 is a prokaryotic protein that binds to the 30S subunit of the ribosome to increase chances of availability for starting protein synthesis. | + | <li>Brief Description: IF-3 is a prokaryotic protein that binds to the 30S subunit of the ribosome to increase chances of availability for starting protein synthesis.</li> |
| − | + | ||
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 157: | Line 181: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683026" target="_blank" class="f12">Elongation Factor- Thermo Unstable (EF-Tu) </a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/9/90/T--Lethbridge--Eftu.png" /></center> | |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443027" target="_blank">BBa_K2443027</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief Description:EF-Tu (elongation factor thermo unstable) is a prokaryotic elongation factor which catalyzes the binding of an aminoacyl-tRNA (aa-tRNA) to the ribosome for the creation of the peptide chain. | + | <li>Brief Description:EF-Tu (elongation factor thermo unstable) is a prokaryotic elongation factor which catalyzes the binding of an aminoacyl-tRNA (aa-tRNA) to the ribosome for the creation of the peptide chain.</li> |
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 172: | Line 199: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683027" target="_blank" class="f12">Elongation Factor-Thermo Stable (EF-Ts)</a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/1/12/T--Lethbridge--Efts.png" /></center> | |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443028" target="_blank">BBa_K2443028</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief Description: EF-Ts is a prokaryotic elongation factor. EF-Ts acts at the guanine nucleotide exchange factor for EF-Tu. It releases GTP from EF-Tu, enabling EF-Tu to bind to a new GTP molecule and catalyze another tRNA addition. | + | <li>Brief Description: EF-Ts is a prokaryotic elongation factor. EF-Ts acts at the guanine nucleotide exchange factor for EF-Tu. It releases GTP from EF-Tu, enabling EF-Tu to bind to a new GTP molecule and catalyze another tRNA addition.</li> |
| − | + | ||
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 188: | Line 217: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683028" target="_blank" class="f12">MyoKinase (MK)</a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/c/ce/T--Lethbridge--MK.PNG" alt="MK construct"></center> | |
| − | <img src="https://static.igem.org/mediawiki/2018/c/ce/T--Lethbridge--MK.PNG" alt="MK construct"> | + | </div></div> |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | |
| − | + | <div style="clear: both"></div> | |
| + | |||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443033" target="_blank">BBa_K2443033</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief Description: Myokinase (MK) is a phosphotransferase enzyme that is responsible for the catalyzing the interconversion of adenine nucleotides (ATP, ADP, and AMP), which is crucial for energy homeostasis in the cell. | + | <li>Brief Description: Myokinase (MK) is a phosphotransferase enzyme that is responsible for the catalyzing the interconversion of adenine nucleotides (ATP, ADP, and AMP), which is crucial for energy homeostasis in the cell.</li> |
| − | + | ||
| − | + | ||
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 206: | Line 236: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683029" target="_blank" class="f12">Nucleoside Diphosphate Kinase (NDK)</a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/0/0f/T--Lethbridge--NDK2018.png" /></center> | |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443035" target="_blank">BBa_K2443035</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief description: NDK is responsible for the exchange of a phosphates between different nucleoside diphosphates (NDP) and triphosphates (NTP). | + | <li>Brief description: NDK is responsible for the exchange of a phosphates between different nucleoside diphosphates (NDP) and triphosphates (NTP).</li> |
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
| Line 221: | Line 254: | ||
<div style="clear: both"></div> | <div style="clear: both"></div> | ||
| − | <div class=" | + | <div class="textImage-Wrapper"> |
| − | <div class=" | + | <div class="textImage-Text"><h2><a href="http://parts.igem.org/Part:BBa_K2683030" target="_blank" class="f12">Peptidyl Prolyl Isomerase (PPiase)</a></h2></div> |
| − | + | <div class="textImage-Image"><center><img src="https://static.igem.org/mediawiki/2018/4/4d/T--Lethbridge--PPiase2018.png" /></center> | |
| − | <ul style="list-style-type:none" class="f11" id="left" | + | </div></div> |
| − | + | ||
| + | <div style="clear: both"></div> | ||
| + | |||
| + | <div class="oneText-Wrapper"><div class="oneText-Text"> | ||
| + | <ul style="list-style-type:none" class="f11" id="left">Original Part: <a href="http://parts.igem.org/Part:BBa_K2443036" target="_blank">BBa_K2443036</a> | ||
<li> Submitted by: Lethbridge iGEM 2017</li> | <li> Submitted by: Lethbridge iGEM 2017</li> | ||
<li>Designed by: iGEM17_Lethbridge</li> | <li>Designed by: iGEM17_Lethbridge</li> | ||
| − | <li>Brief description: This protein catalyzes the addition of the proline amino acid onto the peptide chain during protein synthesis. | + | <li>Brief description: This protein catalyzes the addition of the proline amino acid onto the peptide chain during protein synthesis.</li> |
| − | + | ||
| − | </li> | + | |
</ul> | </ul> | ||
</div> | </div> | ||
Latest revision as of 03:48, 18 October 2018
The following constructs are improved by being cloned and confirmed to be into the pSB1C3 plasmid, thus making them able to express in E. coli and used for iGEM user applications. Our project focuses on encapsulation of cargo by protein nanocompartments. This technology can be used to encapsulate cell free systems. The Next vivo project, designed by the Lethbridge iGEM team in 2017 is therefore an important and viable application for our toolkit. We hope in the future to try encapsulating this system as an alternative to liposome encapsulation as previously proposed for this project. The ability to target cell types could increase the cell free technology we are still developing. Additionally, we hope that cell-free synthesis of protein nanocompartments can also be accomplished using our Next vivo system
- Original Part: BBa_K2443029
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief description: Release factor 1 (RF1) works with release factor 2 and 3 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.
- Original Part: BBa_K2443030
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description: Release factor 2 (RF2) works with release factors 1 and 2 to cause the termination of translation by recognizing the stop codon in the mRNA sequence in question.
- Original Part: BBa_K2443004
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief description: Cysteine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis.
- Original Part: BBa_K2443012
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief description: Lysine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis.
- Original Part: BBa_K2443014
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description: Phenylalanine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis. The alpha subunit is one of the two subunits for this function.
- Original Part: BBa_K2443019
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description: Serine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis.
- Original Part: BBa_K2443023
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description:Valine tRNA synthetase works in the cell by attaching cysteine onto its tRNA to form an aminoacyl-tRNA for protein synthesis.
- Original Part: BBa_K2443024
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description: IF1 is a prokaryotic protein that interacts with the ribosome by binding to the A site, preventing aminoacyl tRNA from entering the ribosome.
- Original Part: BBa_K2443025
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description: IF-3 is a prokaryotic protein that binds to the 30S subunit of the ribosome to increase chances of availability for starting protein synthesis.
- Original Part: BBa_K2443027
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description:EF-Tu (elongation factor thermo unstable) is a prokaryotic elongation factor which catalyzes the binding of an aminoacyl-tRNA (aa-tRNA) to the ribosome for the creation of the peptide chain.
- Original Part: BBa_K2443028
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description: EF-Ts is a prokaryotic elongation factor. EF-Ts acts at the guanine nucleotide exchange factor for EF-Tu. It releases GTP from EF-Tu, enabling EF-Tu to bind to a new GTP molecule and catalyze another tRNA addition.
- Original Part: BBa_K2443033
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief Description: Myokinase (MK) is a phosphotransferase enzyme that is responsible for the catalyzing the interconversion of adenine nucleotides (ATP, ADP, and AMP), which is crucial for energy homeostasis in the cell.
- Original Part: BBa_K2443035
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief description: NDK is responsible for the exchange of a phosphates between different nucleoside diphosphates (NDP) and triphosphates (NTP).
- Original Part: BBa_K2443036
- Submitted by: Lethbridge iGEM 2017
- Designed by: iGEM17_Lethbridge
- Brief description: This protein catalyzes the addition of the proline amino acid onto the peptide chain during protein synthesis.